Updated

The Federal Trade Commission alleges that Martin Shkreli, the former pharmaceutical executive barred for life from the industry, livestreamed himself violating that ban by discussing and promoting biotech stocks. In the stream, Shkreli reportedly joked about his ability to find biotech stocks to promote despite the prohibition. The incident adds to Shkreli's long history of regulatory and legal trouble stemming from drug pricing scandals and securities fraud, and raises questions about the FTC's ability to enforce lifetime industry bans against public figures who continue to broadcast commentary online.